Allergy Laboratories Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial recall — FDA D-1498-2016
Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.
Overview of recall records associated with Allergy Laboratories, Inc., including dates, categories and classifications where available.
Classification mix: Class II: 1.
Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.
This page summarizes recall records in which the official source identifies Allergy Laboratories, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.